Medical Devices - Clinical Trials Arena https://www.clinicaltrialsarena.com/sector/medical-devices/ Hard data and deep insights on clinical trials strategy & operations Thu, 31 Oct 2024 15:41:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Medical Devices - Clinical Trials Arena https://www.clinicaltrialsarena.com/sector/medical-devices/ 32 32 Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial  https://www.clinicaltrialsarena.com/news/sinapticas-neuromodulation-device-aces-phase-ii-alzheimers-trial/ Thu, 31 Oct 2024 13:20:29 +0000 https://www.clinicaltrialsarena.com/uncategorized/sinapticas-neuromodulation-device-aces-phase-ii-alzheimers-trial/ Alzheimer’s patients using the SinaptiStim system experienced a 44% reduction in disease progression over 12-months.

The post Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial  appeared first on Clinical Trials Arena.

]]> The post Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial  appeared first on Clinical Trials Arena.

]]> Nexalin trials Halo neurostimulation device in traumatic brain injury https://www.clinicaltrialsarena.com/news/nexalin-trials-halo-neurostimulation-device-in-traumatic-brain-injury/ Wed, 23 Oct 2024 10:24:46 +0000 https://www.clinicaltrialsarena.com/news/nexalin-trials-halo-neurostimulation-device-in-traumatic-brain-injury/ The study will evaluate the company’s Gen-3 Halo headset as an at-home treatment for mild traumatic brain injury.

The post Nexalin trials Halo neurostimulation device in traumatic brain injury appeared first on Clinical Trials Arena.

]]> The post Nexalin trials Halo neurostimulation device in traumatic brain injury appeared first on Clinical Trials Arena.

]]> Mixed results for Nexalin’s transcranial alternating current stimulation trial https://www.clinicaltrialsarena.com/news/mixed-results-for-nexalins-transcranial-alternating-current-stimulation-trial/ Fri, 18 Oct 2024 14:53:53 +0000 https://www.clinicaltrialsarena.com/uncategorized/mixed-results-for-nexalins-transcranial-alternating-current-stimulation-trial/ Nexalin’s device missed the primary endpoint but produced positive data in secondary endpoint measures.

The post Mixed results for Nexalin’s transcranial alternating current stimulation trial appeared first on Clinical Trials Arena.

]]> The post Mixed results for Nexalin’s transcranial alternating current stimulation trial appeared first on Clinical Trials Arena.

]]> Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease https://www.clinicaltrialsarena.com/news/adaptive-deep-brain-stimulation-trial-results-poised-to-transform-parkinsons-disease/ Thu, 10 Oct 2024 15:20:35 +0000 https://www.clinicaltrialsarena.com/uncategorized/adaptive-deep-brain-stimulation-trial-results-poised-to-transform-parkinsons-disease/ The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.

The post Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease appeared first on Clinical Trials Arena.

]]> The post Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease appeared first on Clinical Trials Arena.

]]> SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study https://www.clinicaltrialsarena.com/news/setpoints-neuromodulation-implant-wins-ide-for-multiple-sclerosis-study/ Thu, 03 Oct 2024 09:28:16 +0000 https://www.clinicaltrialsarena.com/uncategorized/setpoints-neuromodulation-implant-wins-ide-for-multiple-sclerosis-study/ SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

The post SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study appeared first on Clinical Trials Arena.

]]> The post SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study appeared first on Clinical Trials Arena.

]]> Synchron’s BCI meets primary endpoint in feasibility trial https://www.clinicaltrialsarena.com/news/synchrons-bci-meets-primary-endpoint-in-feasibility-trial/ Tue, 01 Oct 2024 15:20:12 +0000 https://www.clinicaltrialsarena.com/uncategorized/synchrons-bci-meets-primary-endpoint-in-feasibility-trial/ Synchron’s study is the first approved by the FDA to test a permanently implanted BCI.

The post Synchron’s BCI meets primary endpoint in feasibility trial appeared first on Clinical Trials Arena.

]]> The post Synchron’s BCI meets primary endpoint in feasibility trial appeared first on Clinical Trials Arena.

]]> Wesper sleep platform reduces nerve stimulation titration time by 45% https://www.clinicaltrialsarena.com/news/wesper-sleep-platform-reduces-nerve-stimulation-titration-time-by-45/ Thu, 26 Sep 2024 09:52:51 +0000 https://www.clinicaltrialsarena.com/?p=217544 A case study found that Wesper’s platform reduces the average titration period for hypoglossal nerve stimulation from 100 days to 55 days.

The post Wesper sleep platform reduces nerve stimulation titration time by 45% appeared first on Clinical Trials Arena.

]]> The post Wesper sleep platform reduces nerve stimulation titration time by 45% appeared first on Clinical Trials Arena.

]]> Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant https://www.clinicaltrialsarena.com/news/bridge-to-life-bolsters-efficacy-data-for-hope-perfusion-device-in-liver-transplant/ Tue, 24 Sep 2024 10:38:02 +0000 https://www.clinicaltrialsarena.com/news/bridge-to-life-bolsters-efficacy-data-for-hope-perfusion-device-in-liver-transplant/ The results from three trials showed that using the company’s perfusion device HOPE improves outcomes in redo-liver transplantation.

The post Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant appeared first on Clinical Trials Arena.

]]> The post Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant appeared first on Clinical Trials Arena.

]]> Synergia implants first patients with neurostimulator for epilepsy treatment https://www.clinicaltrialsarena.com/news/synergia-implants-first-patients-with-neurostimulator-for-epilepsy-treatment/ Mon, 23 Sep 2024 16:31:50 +0000 https://www.clinicaltrialsarena.com/uncategorized/synergia-implants-first-patients-with-neurostimulator-for-epilepsy-treatment/ Synergia’s optoelectronic technology overcomes several hurdles for MRI compatibility.

The post Synergia implants first patients with neurostimulator for epilepsy treatment appeared first on Clinical Trials Arena.

]]> The post Synergia implants first patients with neurostimulator for epilepsy treatment appeared first on Clinical Trials Arena.

]]> Onward implants second patient with brain chip in spinal cord injury trial https://www.clinicaltrialsarena.com/news/onward-implants-second-patient-with-brain-chip-in-spinal-cord-injury-trial/ Thu, 19 Sep 2024 14:39:34 +0000 https://www.clinicaltrialsarena.com/uncategorized/onward-implants-second-patient-with-brain-chip-in-spinal-cord-injury-trial/ Onward Medical has successfully implanted a second patient with a brain computer interface (BCI) system to restore lower limb movement.

The post Onward implants second patient with brain chip in spinal cord injury trial appeared first on Clinical Trials Arena.

]]> The post Onward implants second patient with brain chip in spinal cord injury trial appeared first on Clinical Trials Arena.

]]>